Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N J Thomas

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Pediatric Cardiology|May 12, 2004
Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life supportN J Thomas, J J Messina, W J DeBruin, et al.
Journal of Cardiovascular Pharmacology|June 26, 1998
Effect of the type IV phosphodiesterase inhibitor Ro 20-1724 on catecholamine-induced alterations in regional vascular resistance and regional blood flowN J Thomas, W A Herzer, J A Carcillo, et al.
Veterinary Parasitology|June 8, 2001
Dual Sarcocystis neurona and Toxoplasma gondii infection in a Northern sea otter from Washington state, USAD S Lindsay, N J Thomas, A C Rosypal, et al.
The Journal of Parasitology|May 23, 2003
Sarcocysts of an unidentified species of Sarcocystis in the sea otter (Enhydra lutris)J P Dubey, D S Lindsay, B M Rosenthal, et al.
Journal of Comparative Pathology|April 24, 2012
Osteosarcoma of the maxilla with concurrent osteoma in a southern sea otter (Enhydra lutris nereis)J Rodriguez-Ramos Fernandez, N J Thomas, R R Dubielzig, et al.
Archives of Environmental Contamination and Toxicology|July 16, 2004
Avian mortality events in the United States caused by anticholinesterase pesticides: a retrospective summary of National Wildlife Health Center records from 1980 to 2000M A Fleischli, J C Franson, N J Thomas, et al.
Pediatric Emergency Care|April 1, 1997
Pediatric ECMO for severe quinidine cardiotoxicityF W Tecklenburg, N J Thomas, S A Webb, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrineJ A Carcillo, W A Herzer, Z Mi, et al.
Chest|November 1, 1990
Myocardial revascularization for the third time. Clinical characteristics and follow-upB P Blakeman, N J Thomas, H J Sullivan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrineN J Thomas, J A Carcillo, W A Herzer, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Pediatric Cardiology|May 12, 2004
Cardiac failure in hemolytic uremic syndrome and rescue with extracorporeal life supportN J Thomas, J J Messina, W J DeBruin, et al.
Journal of Cardiovascular Pharmacology|June 26, 1998
Effect of the type IV phosphodiesterase inhibitor Ro 20-1724 on catecholamine-induced alterations in regional vascular resistance and regional blood flowN J Thomas, W A Herzer, J A Carcillo, et al.
Veterinary Parasitology|June 8, 2001
Dual Sarcocystis neurona and Toxoplasma gondii infection in a Northern sea otter from Washington state, USAD S Lindsay, N J Thomas, A C Rosypal, et al.
The Journal of Parasitology|May 23, 2003
Sarcocysts of an unidentified species of Sarcocystis in the sea otter (Enhydra lutris)J P Dubey, D S Lindsay, B M Rosenthal, et al.
Journal of Comparative Pathology|April 24, 2012
Osteosarcoma of the maxilla with concurrent osteoma in a southern sea otter (Enhydra lutris nereis)J Rodriguez-Ramos Fernandez, N J Thomas, R R Dubielzig, et al.
Archives of Environmental Contamination and Toxicology|July 16, 2004
Avian mortality events in the United States caused by anticholinesterase pesticides: a retrospective summary of National Wildlife Health Center records from 1980 to 2000M A Fleischli, J C Franson, N J Thomas, et al.
Pediatric Emergency Care|April 1, 1997
Pediatric ECMO for severe quinidine cardiotoxicityF W Tecklenburg, N J Thomas, S A Webb, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 1, 1996
Treatment with the type IV phosphodiesterase inhibitor Ro 20-1724 protects renal and mesenteric blood flow in endotoxemic rats treated with norepinephrineJ A Carcillo, W A Herzer, Z Mi, et al.
Chest|November 1, 1990
Myocardial revascularization for the third time. Clinical characteristics and follow-upB P Blakeman, N J Thomas, H J Sullivan, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 21, 2000
Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrineN J Thomas, J A Carcillo, W A Herzer, et al.
Pageof 4